Gordian Surgical

What Gordian Surgical does

Gordian Surgical Ltd. is an Israeli medical device company founded in 2012 and headquartered in Misgav, with a US operating entity (Gordian Surgical, Inc.) based in New Jersey. The company designs, develops, and commercializes the TroClose™ 1200, an FDA-cleared integrated trocar and port closure system for laparoscopic and robotic minimally invasive surgery. The device combines port access and fascia closure into a single 2-in-1 instrument, using a needle-less, anchor-based closure mechanism with a 180-degree suture deployment that forms a half-loop knot, reducing tissue tension by 75% versus common full-loop systems (NUIG Feasibility Study, 2013). A multi-center study (Hazzan et al., 2020) reported a 0% port site hernia rate at 1-year follow-up. The device is the only system on the market that does not require pneumoperitoneum or additional visualization for closure.

Gordian Surgical serves hospitals and Ambulatory Surgery Centers performing general, bariatric, and urological laparoscopic and robotic procedures, targeting general surgeons, bariatric surgeons, and urologists. Named reference accounts include Cleveland Clinic, Montefiore Medical Center, SUNY Buffalo School of Medicine, East Sussex Healthcare NHS Hospital, University Hospital of Strasbourg-IRCAD, Krankenhaus Sachsenhausen, and University of Texas McGovern Medical School. As of the data provided, the technology is in use at approximately 150 hospitals across the United States, Europe, Israel, and Latin America, with 4,000+ patients treated.

The business model is hardware sales of the TroClose 1200 device (a single-use consumable-class instrument) to surgical facilities, distributed via direct enterprise field sales and through distributor networks. Pricing is not publicly disclosed and is quote-based. The company is backed by Trendlines Group (incubation and investment), B. Braun (strategic investor with global medical device distribution), and the Israeli Innovation Authority. Leadership includes CEO Eddie Shaw, COO Tahel Perets, Chairman Eran Feldhay (six prior medical device exits via Trendlines Medical), and Chief Medical Director Nissim Geron (Director of the Bariatric Center at HaEmek Medical Center).

Name

Gordian Surgical

Legal name

Gordian Surgical Ltd.

Website

https://gordiansurgical.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Gordian Surgical is an Israeli medical device company that sells the FDA-cleared TroClose 1200, a 2-in-1 integrated trocar and port closure system for laparoscopic and robotic surgery, to hospitals and ambulatory surgery centers globally.

Ownership category

akta.pro rank

Product category

Surgical Instruments

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

akta.pro secondary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Laparoscopic surgical devices
• Port closure systems
• Minimally invasive surgery
• Surgical wound closure
• Trocar devices

Headquarters

HQ city

Misgav

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. TroClose™ Device Sales: Sale of the TroClose™ 1200 integrated trocar and port closure device to hospitals and surgical centers. Medical device capital equipment with associated procedural revenue.
2. Product Distribution: Distribution through distributors as indicated in privacy policy for product distribution to surgeons and healthcare facilities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Gordian Surgical develops and commercializes the TroClose 1200, an FDA-cleared 2-in-1 integrated trocar and port closure device for laparoscopic and robotic minimally invasive surgeries. The single-product system combines port access and automated fascia closure, using a proprietary needle-less anchor-based mechanism with 180-degree suture deployment that reduces tissue tension by 75% versus common full-loop systems. It is sold to hospitals and ambulatory surgery centers to reduce port site hernia rates, decrease postoperative pain, and improve operating room efficiency.

Product overview

Gordian Surgical is a single-product medical device company offering the TroClose™ 1200 Port Closure System. This FDA-cleared integrated trocar and wound closure device is designed for laparoscopic and robotic surgeries, combining port access and automated fascia closure in one device. The product addresses port site hernia complications common in minimally invasive surgery, with clinical evidence demonstrating 0% port site hernia rate at 1-year follow-up across multi-center studies.

Differentiator

Problem solved

Functional benefit

Brands

• TroClose: TroClose™ integrated trocar and wound closure device. The company's flagship 2-in-1 product that combines port access and closure for laparoscopic surgeries.
• TroClose 1200

Products and services

• TroClose 1200 Port Closure System

Quantifiable outcome

• 0% port site hernia rate at 1-year follow-up (Hazzan et al., 2020 multi-center study)
• +2 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Applied Medical: Applied Medical is a privately held surgical device manufacturer with a broad laparoscopic access and trocar portfolio, directly competing with Gordian in the port access and closure category used by general and bariatric surgeons.
• Conmed: Conmed manufactures a portfolio of laparoscopic instruments and port closure devices used in general and gynecologic surgery, directly overlapping with Gordian's target procedures and customer base.
• Teleflex: Teleflex's surgical division offers laparoscopic access and wound closure devices used in general and urological surgery, overlapping with Gordian's port closure use cases.

Broad incumbents

• B. Braun: B. Braun is a global surgical devices incumbent with an extensive trocar and minimally invasive surgery portfolio. B. Braun is also an investor in Gordian, making it both a competitor and strategic partner in port closure.
• Ethicon (Johnson & Johnson): Ethicon is the dominant global surgical stapling, suturing, and trocar manufacturer within J&J MedTech. Its laparoscopic port closure and access portfolio competes head-on with Gordian in hospitals worldwide.
• Medtronic: Medtronic (formerly Covidien) is one of the largest manufacturers of laparoscopic instruments and trocars through its Surgical Innovations business, directly competing in port access and closure for minimally invasive surgery.
• CooperSurgical: CooperSurgical (a CooperCompanies business) manufactures a broad portfolio of minimally invasive surgical instruments including trocars and closure devices for gynecologic and general surgery, comparable to Gordian's MIS offerings.
• Stryker: Stryker's surgical equipment division provides laparoscopic instruments and access devices for hospitals and ASCs, serving as a broader incumbent competitor in minimally invasive surgery ports and closure.

Emerging players

• Lexion Medical: Lexion Medical develops access and insufflation technologies for laparoscopic and robotic surgery, with an overlapping niche in port access workflow innovation comparable to Gordian's integrated approach.

Others

• Intuitive Surgical: Intuitive Surgical is the leading robotic surgery platform (da Vinci) on which TroClose 1200 can be used; while not a direct trocar competitor, Intuitive's platform expansion directly drives Gordian's addressable robotic procedure volumes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/5584956

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gordian Surgical